Abstract
Differences in the time to maximal effect (Tmax) of a series of dopamine receptor antagonists on the self-administration of cocaine are not consistent with their lipophilicity (octanol-water partition coefficients at pH 7.4) and expected rapid entry into the brain after intravenous injection. It was hypothesized that the Tmax reflects the time required for maximal occupancy of receptors, which would occur as equilibrium was approached. If so, the Tmax should be related to the affinity for the relevant receptor population. This hypothesis was tested using a series of nine antagonists having a 2500-fold range of Ki or Kd values for D2-like dopamine receptors. Rats self-administered cocaine at regular intervals and then were injected intravenously with a dose of antagonist, and the self-administration of cocaine was continued for 6 to 10 h. The level of cocaine at the time of every self-administration (satiety threshold) was calculated throughout the session. The satiety threshold was stable before the injection of antagonist and then increased approximately 3-fold over the baseline value at doses of antagonists selected to produce this approximately equivalent maximal magnitude of effect (maximum increase in the equiactive cocaine concentration, satiety threshold; Cmax). Despite the similar Cmax, the mean Tmax varied between 5 and 157 min across this series of antagonists. Furthermore, there was a strong and significant correlation between the in vivo Tmax values for each antagonist and the affinity for D2-like dopamine receptors measured in vitro. It is concluded that the cocaine self-administration paradigm offers a reliable and predictive bioassay for measuring the affinity of a competitive antagonist for D2-like dopamine receptors.
Footnotes
This work was supported by the National Institutes of Health National Institute on Drug Abuse [Grant DA018538, Translational Avant-Garde Award DP1DA031386] (to A.B.N.); a Dalton-Zannoni Undergraduate Research Fellowship from the American Society for Pharmacology and Experimental Therapeutics; and the University of Cincinnati (B.K.F. from a grant to R.W.M.).
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
doi:10.1124/jpet.111.183244.
-
ABBREVIATIONS:
- SCH23390
- (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
- Tmax
- time to maximal effect
- Cmax
- maximum increase in the equiactive cocaine concentration (satiety threshold)
- pA3
- negative logarithm of the antagonist dose (or concentration) required to induce a 3-fold increase in the agonist concentration ratio
- Vd
- volume of distribution
- log D
- distribution coefficient or octanol-water partition coefficient at a defined pH
- log P
- octanol-water partition coefficient.
- Received April 21, 2011.
- Accepted May 19, 2011.
- Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|